Valuation: H&R GmbH & Co. KGaA

Market Cap 252M 281M 233M 211M 395M 26.71B 400M 2.79B 1.11B 14B 1.06B 1.03B 44.39B P/E 2026 *
4.77x
P/E 2027 * 14.5x
Enterprise Value 275M 307M 254M 230M 431M 29.13B 436M 3.05B 1.21B 15.27B 1.15B 1.13B 48.42B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.19x
Free-Float
21.97%
Yield 2026 *
2.21%
Yield 2027 * 1.47%
08-14 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-31 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
11-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25/08/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/08/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
16/05/25 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
14/05/25 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
16/04/25 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
09/04/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
26/03/25 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
Current month-8.38%
1 month-8.63%
3 months+4.63%
6 months+47.39%
Current year+58.04%
1 week 6.38
Extreme 6.38
7.12
1 month 6.38
Extreme 6.38
7.6
Current year 3.91
Extreme 3.91
7.6
1 year 3.91
Extreme 3.91
7.6
3 years 3.23
Extreme 3.23
7.6
5 years 3.23
Extreme 3.23
9.12
10 years 3.23
Extreme 3.23
16.76
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2016
Investor Relations Contact - 01/01/2006
Director TitleAgeSince
Chairman 62 17/04/2012
Director/Board Member 71 01/05/2011
Director/Board Member 69 01/05/2011
Change 5-day change 1-year change 3-year change Capi.($)
-0.59%0.00%+37.25%+39.79% 281M
+0.21%+1.35%+14.35%+37.28% 234B
-0.52%+1.28%+11.33%+31.72% 124B
-2.73%-2.98%-3.00%+38.12% 78.68B
-1.16%+0.51%+591.86%+378.30% 72.76B
+0.45%+1.50%+20.08%+11.21% 68.39B
+3.43%+8.36%-21.19%-37.84% 38.11B
+3.96%+5.13%+12.55%-19.94% 33.01B
-0.62%+10.07%+31.29%-29.79% 24.54B
+3.22%+4.45%+7.58%-6.03% 25.22B
Average +0.62%+2.70%+70.21%+44.28% 69.92B
Weighted average by Cap. +0.06%+1.48%+70.86%+58.62%

Financials

2026 *2027 *
Net sales 1.4B 1.56B 1.3B 1.17B 2.2B 148B 2.22B 15.53B 6.17B 77.81B 5.87B 5.74B 247B 1.37B 1.53B 1.26B 1.15B 2.14B 145B 2.17B 15.16B 6.02B 75.96B 5.73B 5.6B 241B
Net income 52.99M 59.04M 48.93M 44.37M 82.93M 5.61B 83.95M 587M 233M 2.94B 222M 217M 9.32B 17.34M 19.32M 16.01M 14.52M 27.13M 1.83B 27.47M 192M 76.23M 962M 72.52M 70.97M 3.05B
Net Debt 22.87M 25.48M 21.11M 19.15M 35.79M 2.42B 36.23M 253M 101M 1.27B 95.64M 93.59M 4.02B 8.65M 9.64M 7.99M 7.24M 13.54M 916M 13.7M 95.77M 38.03M 480M 36.18M 35.41M 1.52B
Projected Income Statement - Annual - H&R GmbH & Co. KGaA
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,688
Date Price Change Volume
27/10/26 €6.780 -0.59% 18,972
26/10/26 €6.820 +3.02% 11,925
23/10/26 €6.620 -2.65% 37,856
22/10/26 €6.800 +0.29% 2,547
21/10/26 €6.780 0.00% 1,740
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - H&R GmbH & Co. KGaA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.780EUR
Average target price
7.700EUR
Spread / Average Target
+13.57%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - H&R GmbH & Co. KGaA
  1. Stock Market
  2. Stocks
  3. 2HRA Stock